CytomX Therapeutics Competitors and Similar CompaniesClear all

CytomX Therapeutics's competitors and similar companies include Forbius and Ablynx.
CytomX Therapeutics
CytomX Therapeutics
CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform.
Forbius
Forbius
Forbius (also known as Formation Biologics) is a protein engineering company that develops biotherapeutics for the treatment of cancer and fibrotic diseases.
Ablynx
Ablynx
Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments.
Founding Date
Founding Date
2008
Founding Date
2011
Founding Date
2001
Type
Type
Public
Type
Subsidiary
Type
Subsidiary
Tags
Locations
Locations
South San Francisco, US HQ
Locations
Austin, US HQ
Montréal, CA
Locations
Gent, BE HQ
Employees
Employees
15815% increase
Employees
811% decrease
Employees
156

Financial

Revenue (est.)
Revenue (est.)
$101.2m (FY, 2023)
Revenue (est.)
N/A
Revenue (est.)
€85.2m (FY, 2016)
Net income
Net income
($569k) (FY, 2023)
Net income
N/A
Net income
(€1.1m) (FY, 2016)

Operating

Patents (Foreign)
Patents (Foreign)
4 (FY, 2016)
Patents (Foreign)
N/A
Patents (Foreign)
180 (Q2, 2017)
Patents (US)
Patents (US)
13 (FY, 2016)
Patents (US)
N/A
Patents (US)
50 (Q2, 2017)

Funding

Total funding raised
Total funding raised
$ 132.4m
Total funding raised
N/A
Total funding raised
$ 498.8m
For sources of this data, please see the company profile

View Company Profiles

Forbius
HQ
Austin, US

Forbius (also known as Formation Biologics) is a protein engineering company that develops biotherapeutics for the treatment of cancer and fibrotic diseases.

View company
Ablynx
HQ
Gent, BE

Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments.

View company